Pentagon cuts back shots for anthrax

Associated Press

WASHINGTON — Because of dwindling vaccine supplies, the Pentagon will cut back further on its plan to immunize all troops against the deadly anthrax virus, officials announced Thursday.

Under the change, only troops that will serve in the Persian Gulf for at least 30 days will receive the shot, said spokesman Kenneth Bacon. Forces deployed in South Korea, the only others currently receiving the vaccine under a program curtailed to preserve scarce supplies, no longer will be vaccinated.

"Given the fact that Saddam Hussein has used chemical weapons in the past against Iran and against the Kurdish minority in his own country, we assess the risk to be greater in Iraq than we do right now in the Korean Peninsula," Bacon said.

"This is in order to conserve supplies while continuing to protect the people going to the highest-threat area," he said.

The Defense Department’s only vaccine supplier, Bioport of Lansing, Mich., has experienced delays in obtaining certification and starting up its new manufacturing plant, which may not be operational for another year.

The Pentagon at first wanted to vaccinate all service members but cut back in the summer to only those serving in the Persian Gulf area and in Korea. Usage is running at about 17,000 doses a month.

The supply has since fallen to about 60,000 doses, meaning there is enough to give 5,000 shots a month to gulf troops for a year, Bacon said. He said officials hope Bioport will receive approval and be producing more vaccine by the third or fourth quarter of next year, and the Pentagon is working to find an alternate supplier as well.

He also asserted once again that the program is safe. A relatively small, but vocal, number of military members have refused to take the vaccine, saying they fear potentially damaging side effects.